GARIBOLDI MARZIA BRUNA

From the early years of her career, Dr. Gariboldi has focused on the study of the molecular determinants of cellular responses to anticancer agents, investigating the role of multidrug resistance–related transporters and signal transduction pathways involved in cell survival and the control of apoptosis. More recently, she has also examined the role of hypoxia in the sensitivity of tumor cells to chemotherapy. Current research lines also include the study of newly synthesized photosensitizing agents for use in photodynamic therapy of tumors and the evaluation of new platinum derivatives and naturally derived substances as anticancer agents.